MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm14113654

Медицинская библиотека · Journal of clinical medicine · 2025

Dupilumab-Induced Remission in Chronic Rhinosinusitis with Nasal Polyps and Comorbid Asthma: A 24-Month Study.

Tajiri Tomoko, Suzuki Motohiko, Nishiyama Hirono, Ozawa Yoshiyuki, Amakusa Yuki, Suzuki Tatsuro, Ito Keima, Mori Yuta, Fukumitsu Kensuke, Fukuda Satoshi, Kanemitsu Yoshihiro, Uemura Takehiro, Ohkubo Hirotsugu, Takemura Masaya, Ito Yutaka, Oguri Tetsuya, Niimi Akio

СтатьяПеревод в очереди

Аннотация

Background

When considering the effects of dupilumab on severe chronic rhinosinusitis with nasal polyps (CRSwNPs), dupilumab is expected to achieve CRSwNPs remission. The aim of this study was to assess the rate of remission of CRSwNPs with comorbid asthma and its predictors on a 24-month course of dupilumab.

Methods

Adult patients with severe CRSwNPs and comorbid asthma who had completed a 24-month course of dupilumab were included in this post hoc analysis. The primary outcome was the rate of CRSwNPs remission at 12 and 24 months of dupilumab. The secondary outcome was to identify factors associated with CRSwNPs remission at 12 and 24 months. Based on the European criteria and a previous definition, remission was defined as the absence of symptoms, improved quality of life, no need for surgery, no exacerbations, recovery of olfactory function, and inactive disease by nasal endoscopy for ≥12 months. A rigorous six-component remission, including olfactory testing, was initially used.

Results

Of 16 patients, 4 (25%) and 5 (31%) achieved six-component remission of CRSwNPs at 12 and 24 months, respectively. Patients with shorter disease duration and better olfactory function at baseline achieved six-component remission of CRSwNPs more frequently than those without at 24 months (both p < 0.05).

Conclusions

Remission of severe CRSwNPs with comorbid asthma is attainable with a 24-month course of dupilumab.

Для цитирования: Tajiri Tomoko, Suzuki Motohiko, Nishiyama Hirono, Ozawa Yoshiyuki, Amakusa Yuki, Suzuki Tatsuro, Ito Keima, Mori Yuta, Fukumitsu Kensuke, Fukuda Satoshi, Kanemitsu Yoshihiro, Uemura Takehiro, Ohkubo Hirotsugu, Takemura Masaya, Ito Yutaka, Oguri Tetsuya, Niimi Akio. Dupilumab-Induced Remission in Chronic Rhinosinusitis with Nasal Polyps and Comorbid Asthma: A 24-Month Study.. Journal of clinical medicine. 2025. DOI: 10.3390/jcm14113654.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.